• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降钙素原、C 反应蛋白和白细胞介素-6 在指导慢性阻塞性肺疾病急性加重患者使用抗生素中的临床意义。

Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

机构信息

State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi, 830000, China.

First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China.

出版信息

Dis Markers. 2021 Mar 15;2021:8879401. doi: 10.1155/2021/8879401. eCollection 2021.

DOI:10.1155/2021/8879401
PMID:33791046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7984918/
Abstract

BACKGROUND

Currently, standards of antibiotic use in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) patients are controversial.

OBJECTIVE

The aim of the present study was to analyze the value of procalcitonin (PCT), C-reactive protein (CRP), and interleukin-6 (IL-6) levels to guide the antibiotic treatment of AECOPD patients.

METHODS

A total of 371 patients with COPD or AECOPD were included in the study. Clinical and laboratory data were obtained at admission, 325 AECOPD patients and 46 sCOPD patients treated with antibiotics. The receiver operating curve (ROC) was used to evaluate the relationship between CRP, PCT, and IL-6.

RESULTS

This study included medical record/case control 1, the COPD group ( = 46) and the AECOPD group ( = 325), and medical record control 2, the nonchanged antibiotic group ( = 203) and the changed antibiotic group ( = 61). In case 1, CRP, PCT, and IL-6 levels in the AECOPD group were higher than that in the control group ( < 0.05), while the result of ROC showed that IL-6 had higher AUC values (0.773) and higher sensitivity (71.7%) than other indicators. The specificity of PCT (93.5%) is higher than other indicators. In case 2, ROC curve results showed that the AUC value of IL-6 (0.771) was slightly higher than PCT and CRP. The sensitivity (85.2%) and specificity (65.5%) of CRP were higher than other indicators.

CONCLUSIONS

IL-6 and PCT were elevated in AECOPD patients, resulting in a higher diagnostic value for AECOPD. CRP had a higher diagnostic value for antibiotic use in AECOPD patients.

摘要

背景

目前,慢性阻塞性肺疾病急性加重(AECOPD)患者抗生素使用标准存在争议。

目的

本研究旨在分析降钙素原(PCT)、C 反应蛋白(CRP)和白细胞介素 6(IL-6)水平对 AECOPD 患者抗生素治疗的指导价值。

方法

共纳入 371 例 COPD 或 AECOPD 患者。入院时采集临床和实验室数据,对 325 例 AECOPD 患者和 46 例 sCOPD 患者进行抗生素治疗。采用受试者工作特征曲线(ROC)评估 CRP、PCT 和 IL-6 之间的关系。

结果

本研究包括病历/病例对照 1,COPD 组(n=46)和 AECOPD 组(n=325),以及病历对照 2,未改变抗生素组(n=203)和改变抗生素组(n=61)。在病例 1 中,AECOPD 组 CRP、PCT 和 IL-6 水平高于对照组(P<0.05),而 ROC 结果显示,IL-6 的 AUC 值(0.773)和灵敏度(71.7%)均高于其他指标。PCT(93.5%)的特异性高于其他指标。在病例 2 中,ROC 曲线结果显示,IL-6(0.771)的 AUC 值略高于 PCT 和 CRP。CRP 的灵敏度(85.2%)和特异性(65.5%)高于其他指标。

结论

AECOPD 患者 IL-6 和 PCT 升高,对 AECOPD 的诊断价值较高。CRP 对 AECOPD 患者抗生素使用具有更高的诊断价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ef/7984918/7fae4e001904/DM2021-8879401.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ef/7984918/abc21f48321f/DM2021-8879401.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ef/7984918/7f18b6247d66/DM2021-8879401.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ef/7984918/7fae4e001904/DM2021-8879401.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ef/7984918/abc21f48321f/DM2021-8879401.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ef/7984918/7f18b6247d66/DM2021-8879401.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ef/7984918/7fae4e001904/DM2021-8879401.003.jpg

相似文献

1
Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.降钙素原、C 反应蛋白和白细胞介素-6 在指导慢性阻塞性肺疾病急性加重患者使用抗生素中的临床意义。
Dis Markers. 2021 Mar 15;2021:8879401. doi: 10.1155/2021/8879401. eCollection 2021.
2
Correlations between serum amyloid A, C-reactive protein and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease.血清淀粉样蛋白 A、C 反应蛋白与慢性阻塞性肺疾病急性加重期患者临床指标的相关性。
J Clin Lab Anal. 2019 May;33(4):e22831. doi: 10.1002/jcla.22831. Epub 2019 Jan 21.
3
Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.降钙素原、C反应蛋白及血中性粒细胞/淋巴细胞比值水平对慢性阻塞性肺疾病急性加重期住院患者细菌感染预测的诊断价值比较
Wien Klin Wochenschr. 2015 Oct;127(19-20):756-63. doi: 10.1007/s00508-014-0690-6. Epub 2015 Jan 14.
4
Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study.血清降钙素原预测慢性阻塞性肺疾病细菌感染诱发急性加重的最佳截断值:一项前瞻性观察研究。
Chron Respir Dis. 2022 Jan-Dec;19:14799731221108516. doi: 10.1177/14799731221108516.
5
Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbations of COPD: A prospective observational study.比较降钙素原、C 反应蛋白、白细胞计数和临床状况在诊断住院治疗 COPD 急性加重患者肺炎中的作用:一项前瞻性观察研究。
Chron Respir Dis. 2019 Jan-Dec;16:1479972318769762. doi: 10.1177/1479972318769762. Epub 2018 May 30.
6
Assessment value of interleukin-6, procalcitonin, and C-reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: A prospective study.白细胞介素-6、降钙素原和 C 反应蛋白早期动力学对发热性中性粒细胞减少症患者初始抗生素疗效的评估价值:一项前瞻性研究。
Cancer Med. 2024 Jul;13(13):e7307. doi: 10.1002/cam4.7307.
7
The predictive value of serum procalcitonin for non-invasive positive pressure ventilation in the patients with acute exacerbation of chronic obstructive pulmonary disease.降钙素原对慢性阻塞性肺疾病急性加重患者无创正压通气的预测价值。
Medicine (Baltimore). 2021 Apr 23;100(16):e25547. doi: 10.1097/MD.0000000000025547.
8
Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.降钙素原与 C 反应蛋白在 COPD 急性加重期抗生素治疗反应预测标志物中的比较。
Chest. 2010 Nov;138(5):1108-15. doi: 10.1378/chest.09-2927. Epub 2010 Jun 24.
9
Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance.降钙素原和其他标志物在抗菌药物耐药时代指导慢性阻塞性肺疾病加重的抗生素使用。
Curr Opin Pulm Med. 2019 Mar;25(2):158-164. doi: 10.1097/MCP.0000000000000555.
10
Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.包括新蝶呤在内的炎症参数在肺炎、慢性阻塞性肺疾病及急性加重期的诊断和预后价值
COPD. 2017 Jun;14(3):298-303. doi: 10.1080/15412555.2016.1266317. Epub 2017 Feb 28.

引用本文的文献

1
Association Between Neutrophil-Lymphocyte Ratio and All-Cause Mortality in Critically Ill Patients with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study.中性粒细胞与淋巴细胞比值与慢性阻塞性肺疾病重症患者全因死亡率的关系:一项回顾性队列研究。
Med Sci Monit. 2023 Feb 14;29:e938554. doi: 10.12659/MSM.938554.
2
Environmental and Genetic Factors in the Pathogenesis of COPD in the Road-Working Population.道路作业人群中 COPD 发病的环境和遗传因素。
Dis Markers. 2021 Apr 29;2021:9953234. doi: 10.1155/2021/9953234. eCollection 2021.

本文引用的文献

1
C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.C 反应蛋白即时检测用于安全减少慢性阻塞性肺疾病急性加重期抗生素使用的研究:PACE RCT。
Health Technol Assess. 2020 Mar;24(15):1-108. doi: 10.3310/hta24150.
2
Expression and clinical significance of serum amyloid A and interleukin-6 in patients with acute exacerbation of chronic obstructive pulmonary disease.血清淀粉样蛋白A和白细胞介素-6在慢性阻塞性肺疾病急性加重期患者中的表达及临床意义
Exp Ther Med. 2020 Mar;19(3):2089-2094. doi: 10.3892/etm.2019.8366. Epub 2019 Dec 20.
3
Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
血清降钙素原在预测严重 COPD 加重期细菌恶化和指导抗生素治疗中的作用:系统评价和荟萃分析。
Infect Dis (Lond). 2019 Sep;51(9):639-650. doi: 10.1080/23744235.2019.1644456. Epub 2019 Jul 29.
4
C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations.C 反应蛋白检测指导 COPD 加重期抗生素的使用。
N Engl J Med. 2019 Jul 11;381(2):111-120. doi: 10.1056/NEJMoa1803185.
5
Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease.降钙素原检测及抗生素在慢性阻塞性肺疾病急性加重期的应用介绍。
Infect Dis (Auckl). 2019 Jun 12;12:1178633719852626. doi: 10.1177/1178633719852626. eCollection 2019.
6
Procalcitonin, C-reactive protein, PaCO2, and noninvasive mechanical ventilation failure in chronic obstructive pulmonary disease exacerbation.降钙素原、C反应蛋白、动脉血二氧化碳分压与慢性阻塞性肺疾病急性加重期无创机械通气失败的关系
Medicine (Baltimore). 2019 Apr;98(17):e15171. doi: 10.1097/MD.0000000000015171.
7
Is Interleukin-6 a better predictor of successful antibiotic therapy than procalcitonin and C-reactive protein? A single center study in critically ill adults.白细胞介素-6 比降钙素原和 C 反应蛋白更能预测抗生素治疗的成功吗?一项重症成人患者的单中心研究。
BMC Infect Dis. 2019 Feb 13;19(1):150. doi: 10.1186/s12879-019-3800-2.
8
Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD.在稳定期慢性阻塞性肺疾病(COPD)中,I型胶原周转指标的血清水平发生改变,同时伴有白细胞介素-6(IL-6)和白细胞介素-8(IL-8)的释放。
Int J Chron Obstruct Pulmon Dis. 2019 Jan 3;14:163-168. doi: 10.2147/COPD.S188139. eCollection 2019.
9
Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance.降钙素原和其他标志物在抗菌药物耐药时代指导慢性阻塞性肺疾病加重的抗生素使用。
Curr Opin Pulm Med. 2019 Mar;25(2):158-164. doi: 10.1097/MCP.0000000000000555.
10
Antibiotics for exacerbations of chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病加重期的抗生素
Cochrane Database Syst Rev. 2018 Oct 29;10(10):CD010257. doi: 10.1002/14651858.CD010257.pub2.